Ventas (VTR)

NYSE Real Estate Health Care REITs S&P 500
$88.75
-0.29 (-0.33%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Trailing 12-month EPS
$0.52
Diluted, last four reported quarters

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Oct 27, 2026Sep/2026$0.98$0.99+1.0%

Our record of VTR's reports since we began tracking; it grows each quarter.

Latest results, in brief

All VTR 8-K briefs →
Oct 27, 4:32 PM ET

Ventas raises 2026 guidance as Q3 normalized FFO rises 10% to $0.99 per share

Mixed earnings 2.02

Ventas reported third-quarter 2026 results with total revenues of $1.83 billion, up from $1.49 billion a year earlier, and normalized FFO of $0.99 per share, up from $0.90. GAAP net income attributable to common stockholders fell to $0.13 per share from $0.14, while the company raised its full-year 2026 guidance, primarily due to senior housing investment activity.

  • Q3 normalized FFO per share was $0.99 versus $0.90 a year earlier; Nareit FFO was $1.01 versus $0.88.
  • Q3 net income attributable to common stockholders was $0.13 per share versus $0.14, down 7%.
  • 2026 normalized FFO per share guidance range was raised to $3.87 to $3.90 from $3.85 to $3.90, with the midpoint at $3.89 versus $3.88.
  • Ventas closed $1.2 billion of senior housing investments in the third quarter and $5.2 billion year to date; net debt to further adjusted EBITDA was 4.4x.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$1.83B+23.0% $0.13-7.1% $65.38M3.6%
Jun 2026$1.73B+21.7% $0.14-6.7% $70.57M4.1%
Mar 2026$1.66B+22.0% $0.11+10.0% $55.91M3.4%
Dec 2025$1.57B+21.7% $0.14+7.7% $70.20M4.5%
Sep 2025$1.49B+20.4% $0.14+180.0% $66.05M4.4%
Jun 2025$1.42B+18.3% $0.15+200.0% $68.26M4.8%
Mar 2025$1.36B+13.2% $0.10— $46.87M3.5%
Dec 2024$1.29B+10.5% $0.13— $56.84M4.4%

From Ventas's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$5.83B+18.5% $0.54+184.2%4.3%
FY2024$4.92B+9.5% $0.19—1.6%
FY2023$4.50B+8.9% $-0.10—-0.9%
FY2022$4.13B+7.9% $-0.12-192.3%-1.1%
FY2021$3.83B+0.9% $0.13-88.9%1.3%

Frequently asked questions

When is Ventas's next earnings date?

Ventas has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Ventas earn last quarter?

For the quarter ended Sep 2026, Ventas reported diluted EPS of $0.13 (-7.1% year over year) on revenue of $1.83B (+23.0%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.